DUBLIN--(BUSINESS WIRE)--The "Translational Regenerative Medicines - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.
According to this research, the Global Translational Regenerative Medicines Market is growing at a CAGR of 13.9% from 2017 to 2026.
Factors such as the increasing prevalence of degenerative diseases, rise in aging population and growing advancements in developed countries are the major driving factors. However, ethical concerns related to the use of embryonic stem cells in research & development hinders market growth.
By Product Type, the Gene therapy segment is expected to have significant growth during the forecast period. Gene therapy assists the foundation for innovative treatments of innumerable musculoskeletal disorders. By geography, North America dominated the global regenerative medicine market owing to an increased number of leading companies and growth in the expansion of research and development activities in the U.S.
Some of the key players profiled in the Translational Regenerative Medicines Market include Vericel Corporation, Gamida Cell Ltd., Athersys, Inc., Orthofix International N.V, Anika Therapeutics, Novartis, Celgene Corporation, Brainstorm Cell Therapeutics Inc., Nuvasive, Inc., and Medipost.
What the report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered
1 Executive Summary
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
3 Market Trend Analysis
3.6 Product Analysis
3.7 Application Analysis
3.8 Emerging Markets
3.9 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Translational Regenerative Medicines Market, By Product Type
6 Global Translational Regenerative Medicines Market, By Therapy
6.2 Gene Therapy
6.3 Cell Therapy
6.5 Tissue Engineering
7 Global Translational Regenerative Medicines Market, By Application
7.8 Other Applications
8 Global Translational Regenerative Medicines Market, By Geography
8.2 North America
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.5 Other Key Strategies
10 Company Profiling
10.1 Vericel Corporation
10.2 Gamida Cell Ltd.
10.3 Athersys Inc.
10.4 Orthofix International N.V
10.5 Anika Therapeutics
10.7 Celgene Corporation
10.8 Brainstorm Cell Therapeutics Inc.
10.9 Nuvasive Inc.
For more information about this report visit https://www.researchandmarkets.com/r/va5aci